Vacancy for Associate Scientist at Novartis | M.Pharm, Ph.D
A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.
Post : Associate Scientist - Formulations

Cerner is a place where people are encouraged to innovate with confidence and focus on what is important – people’s health and the care they receive. We are transforming health care by developing tools and technologies that make it more efficient for care providers and patients to navigate the complexity of our health. From single offices to entire countries, Cerner solutions are licensed at more than 25,000 facilities in over 35 countries.
Mahatma Gandhi Institute of Pharmacy (MGIP) was established in 2008. The Institute is approved by PCI, AICTE and affiliated to UPTU, Lucknow. It is offering Bachelor of Pharmacy (B.Pharm) and Master of Pharmacy (M.Pharm). MGIP is committed to provide world class education with specialized and experienced faculty members along with state-of-the-art facilities, including a modern practice lab that allows students to gain real-time experience in a functioning pharmacy.MGIP came into existence since 2008, is exclusively consecrated in the field of Pharmaceutical education & research and continuously generating pharmacy graduates and post graduates. It's also offering opportunities to contribute to the pharmaceutical industry right from licensed pharmacists to pharmaceutical scientists who develop the medications.
Aries Pharmaceuticals, Inc. (Aries) is a wholly owned subsidiary of Aries Pharmaceuticals, Ltd., which is a wholly owned Subsidiary of Cosmo Pharmaceuticals, NV, a specialty pharmaceutical and medical device company focused on developing and commercializing best in class products in endoscopy and to treat gastrointestinal diseases. The Aries portfolio of four products, three of which are still in development, is licensed from Cosmo Pharmaceuticals N.V. to Aries Pharmaceuticals, Ltd.
